| Market Cap | 21.15B | P/E | 36.05 | EPS this Y | 455.60% | Ern Qtrly Grth | -48.10% |
| Income | 139.73M | Forward P/E | 31.91 | EPS next Y | 18.70% | 50D Avg Chg | 4.00% |
| Sales | 3.01B | PEG | -6.59 | EPS past 5Y | -15.75% | 200D Avg Chg | -10.00% |
| Dividend | 4.00% | Price/Book | 1.13 | EPS next 5Y | -5.92% | 52W High Chg | -29.00% |
| Recommedations | 2.20 | Quick Ratio | 2.67 | Shares Outstanding | 174.93M | 52W Low Chg | 12.00% |
| Insider Own | 0.94% | ROA | 1.35% | Shares Float | 172.61M | Beta | 1.17 |
| Inst Own | 95.50% | ROE | 1.49% | Shares Shorted/Prior | 2.81M/2.53M | Price | 122.22 |
| Gross Margin | 70.88% | Profit Margin | 5.09% | Avg. Volume | 1,004,537 | Target Price | 136.58 |
| Oper. Margin | 27.94% | Earnings Date | Oct 21 | Volume | 854,838 | Change | 0.13% |
Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500® company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. As the pioneer of the life science real estate niche since our founding in 1994, Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative life science mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. Alexandria has a total market capitalization of $34.4 billion and an asset base in North America of 74.1 million SF as of March 31, 2024, which includes 42.2 million RSF of operating properties, 5.3 million RSF of Class A/A+ properties undergoing construction and one committed near-term project expected to commence construction in the next two years, 2.5 million RSF of priority anticipated development and redevelopment projects, and 24.1 million SF of future development projects. Alexandria has a longstanding and proven track record of developing Class A/A+ properties clustered in life science mega campuses that provide our innovative tenants with highly dynamic and collaborative environments that enhance their ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.
| Citigroup | Neutral | Sep 13, 24 |
| Evercore ISI Group | In-Line | Aug 28, 24 |
| RBC Capital | Outperform | Aug 5, 24 |
| Jefferies | Hold | Aug 2, 24 |
| B of A Securities | Neutral | Jul 29, 24 |
| Evercore ISI Group | In-Line | Jul 25, 24 |
| Wedbush | Neutral | Jul 24, 24 |
| JMP Securities | Market Outperform | Jul 23, 24 |
| Evercore ISI Group | Outperform | Jul 16, 24 |
| Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Cunningham John H | EVP - Regional Marke.. EVP - Regional Market Director | Feb 07 | Sell | 165.78 | 7,800 | 1,293,084 | 62,586 | 02/09/23 |
| MARCUS JOEL S | Executive Chairman Executive Chairman | Feb 07 | Sell | 168 | 9,000 | 1,512,000 | 388,729 | 02/09/23 |
| Binda Marc E | EVP - Finance & Trea.. EVP - Finance & Treasurer | Feb 06 | Sell | 167.21 | 3,298 | 551,459 | 67,005 | 02/08/23 |
| Lee Orraparn C. | EVP - Accounting EVP - Accounting | Feb 06 | Sell | 167.11 | 4,800 | 802,128 | 33,619 | 02/08/23 |
| Kass Hunter | EVP - Regional Marke.. EVP - Regional Market Director | Feb 06 | Sell | 167.45 | 3,803 | 636,812 | 87,850 | 02/08/23 |
| CIRUZZI VINCENT | Chief Development Of.. Chief Development Officer | Aug 11 | Sell | 167.83 | 2,016 | 338,345 | 51,929 | 08/15/22 |
| Freire Maria C | Director Director | Jul 28 | Sell | 163.82 | 2,600 | 425,932 | 2,711 | 08/01/22 |
| Cain James P | Director Director | Mar 16 | Sell | 193.26 | 425 | 82,136 | 4,883 | 03/18/22 |
| Diamond Lawrence J | Co-Chief Operating O.. Co-Chief Operating Officer | Feb 24 | Sell | 190.21 | 3,950 | 751,330 | 91,717 | 02/28/22 |
| Hakman Joseph | Co-Chief Operating O.. Co-Chief Operating Officer | Feb 18 | Sell | 186 | 2,435 | 452,910 | 36,883 | 02/23/22 |
| CIRUZZI VINCENT | Chief Development Of.. Chief Development Officer | Feb 18 | Sell | 185.68 | 3,593 | 667,148 | 52,002 | 02/23/22 |
| Moglia Peter M | Co-Chief Executive O.. Co-Chief Executive Officer | Feb 16 | Sell | 186.02 | 5,500 | 1,023,110 | 174,988 | 02/18/22 |
| Kass Hunter | EVP - Regional Marke.. EVP - Regional Market Director | Feb 16 | Sell | 184.96 | 5,544 | 1,025,418 | 41,105 | 02/18/22 |